Feinstein Institute
350 Community Drive
Manhasset
New York
11030
United States
Tel: 516-562-3467
115 articles about Feinstein Institute
-
New Digital Tool Dramatically Reduces Blood Clot Risk During and Post-Hospital Care, Feinstein Institutes Study Shows
11/7/2022
Every year, approximately 8 million Americans are susceptible to dangerous, often fatal blood clots when they are admitted to the hospital for a medical illness such as stroke or an infection like COVID-19.
-
High-frequency Electrical Stimulation Helps Reduce Inflammation, Pain in New Feinstein Institutes Study
10/5/2022
A bump, bruise or broken bone is painful. And while pain is an important defense mechanism to protect the body and promote healing, chronic pain can be debilitating.
-
Feinstein Institutes’ Betty Diamond receives Women in Medicine and Science Leadership Award
10/3/2022
For her dedication to empowering women in science, breakthrough achievements in molecular medicine and research contributions, The Feinstein Institutes for Medical Research’s Betty Diamond, MD, has been awarded the 2022 Association of American Medical Colleges Group on Women in Medicine and Science Leadership Award.
-
Gov. Hochul Tours Renovated Feinstein Institutes Bioelectronic Medicine Lab, Announces First $10 Million Award
9/27/2022
During a special event, The Feinstein Institutes for Medical Research, the research home of Northwell Health, and Governor Kathy Hochul announced the completion of a $35 million, 20,000-square-foot renovation project meant to energize future breakthroughs in bioelectronic medicine.
-
Feinstein Institutes Researchers Identify Potential Drug to Treat Sepsis
8/29/2022
Each year, more than 48 million cases of sepsis are diagnosed and account for 11 million deaths annually.
-
Feinstein Institutes’ Researcher Shares Concerns About Embryo Screening
8/2/2022
Genetic testing has been part of the in vitro fertilization process for three decades and allows parents to screen embryos for illnesses.
-
Feinstein Institutes’ Betty Diamond Elected to the National Academy of Sciences
5/4/2022
The National Academy of Sciences has elected The Feinstein Institutes for Medical Research’s Betty Diamond, MD, in recognition of her breakthrough achievements in molecular medicine and original research.
-
Ross Prize awarded to mRNA technology, COVID-19 vaccine innovators
4/27/2022
The Feinstein Institutes for Medical Research has selected two scientists from the University of Pennsylvania Perelman School of Medicine, Katalin Karikó, PhD, and Drew Weissman, MD, PhD, as awardees of the ninth annual Ross Prize in Molecular Medicine for their tireless research in messenger RNA technology and contributions to developing mRNA-based vaccines to prevent the coronavirus disease 2019.
-
Feinstein Institutes Names Dr. Anil K. Malhotra Co-Director of the Institute of Behavioral Science
2/10/2022
The Feinstein Institutes for Medical Research, the research home of Northwell Health, has named Anil K. Malhotra, MD, co-director of the Institute of Behavioral Science.
-
Race, Socioeconomic Factors Skew Skin Cancer Survival, Feinstein Institutes Study Finds
2/9/2022
Acral lentiginous melanoma is a form of skin cancer that disproportionately affects minority groups.
-
Inflammation Protein Contributes to Anemia of Chronic Disease by Preventing Red Blood Cell Formation
1/18/2022
More than one billion people worldwide suffer from anemia of inflammation or anemia of chronic diseases – and for the first time we may know why. New research from The Feinstein Institutes for Medical Research, published in Blood, shows that high mobility group box-1 protein prevents the body’s ability to produce sufficient levels of oxygen-rich red blood cells.
-
CORRECTING and REPLACING CAPTION Inflammation Protein Contributes to Anemia of Chronic Disease by Preventing Red Blood Cell Formation
1/18/2022
More than one billion people worldwide suffer from anemia of inflammation or anemia of chronic diseases (ACD) – and for the first time we may know why. New research from The Feinstein Institutes for Medical Research, published in Blood, shows that high mobility group box-1 protein (HMGB1) prevents the body’s ability to produce sufficient levels of oxygen-rich red blood cells.
-
Feinstein Institutes’ Christina Brennan Named to Association of Clinical Research Professionals Board
1/7/2022
Christina Brennan, MD, MBA, vice president of clinical research at Northwell Health’s Feinstein Institutes for Medical Research, has been elected by members of the Association of Clinical Research Professionals to serve on its Board of Trustees for a second term.
-
Moderna COVID-19 Vaccine Clinical Trial for People With Organ Transplant Starts at Feinstein Institutes
9/21/2021
In a new clinical trial looking at the efficacy of a third Moderna vaccine dose for coronavirus disease 2019 (COVID-19) in people living with an organ (liver or kidney) transplant, The Feinstein Institutes for Medical Research administered the extra vaccine to the first set of patients in the United States on September 20.
-
Hearing Restoration For The Deaf: Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL
9/15/2021
Blackrock Neurotech, a leading provider of brain computer interface technology for human patients, has announced plans to invest in a novel auditory nerve implant device that restores hearing for the deaf.
-
In a preclinical study published in PNAS, scientists from Feinstein Institutes for Medical Research presented a new approach to treating diseases that involve inflammation and pain, like arthritis.
-
Feinstein Institutes Scientists Develop Long-Term Vagus Nerve Implant for Bioelectronic Medicine Research
4/19/2021
Researchers at the Institute of Bioelectronic Medicine at The Feinstein Institutes for Medical Research developed a long-term implant model for vagus nerve stimulation (VNS) in mice that successfully modulates heart rate and inflammatory proteins. The device and procedure may change the way preclinical bioelectronic medicine research is conducted and lead to alternative therapies for various chronic diseases, includ
-
New Schizophrenia Genetic Mutation Discovered by Feinstein Institutes Researchers
3/22/2021
Researchers at The Feinstein Institutes for Medical Research , in collaboration with Columbia University, have identified a gene mutation that could result in schizophrenia, a chronic brain disorder that affects nearly one percent of the world’s population .
-
Feinstein Institutes Awarded More Than $4M to Research Perinatal Depression
1/15/2021
To study perinatal depression in women – before and after childbirth – and possible new treatments, The Feinstein Institutes for Medical Research has been awarded more than $4 million in multi-year grants.
-
Feinstein Institutes Receives $1.7M Grant to Study Behavior Change Science, Promote Exercise in Older Adults
9/9/2020
Only half of the adults in the United States get the exercise they need to help reduce and prevent chronic diseases.